Continental Dairy Facilities Southwest LLC recalled more than 79,000 pounds of Costco Kirkland Signature butter last month because the packaging may not have an allergen disclaimer about milk. The recalled 46,800 pounds of Kirkland Signature Unsalted Sweet Cream Butter and 32,400 pounds of Kirkland Signature Salted Sweet Cream Butter “list cream, but may be missing

Ark Invest CEO Cathie Wood sees a bright future ahead with President-elect Trump’s return to the White House and predicted over the weekend that his policy agenda will likely usher in economic growth not seen in decades. In a post-election message to investors released Sunday, Wood likened America’s current economic situation to the early 1980s

Home prices are reaching new all-time highs, but those prices may be built on outdated assumptions about climate risk, J.P. Morgan analysts warned in a new note. ​Read More

Scott Boatwright is getting the permanent CEO nod. Chipotle’s stock is up 500% since he joined the company in 2017. ​Read More

Live Nation Entertainment Inc. said late Monday it had its most active summer concert season ever, and its pipeline for 2025 is looking good as well, with big names such as Shakira and Coldplay on tap. ​Read More

Small-cap stocks are on a tear this month, as investors question the sustainability of the rally and the future path of interest rates after President-elect Donald Trump enters the White House in January. ​Read More

Renowned economist Peter Schiff has issued a stark warning about the U.S. read more ​  ​Renowned economist Peter Schiff has issued a stark warning about the U.S. read more 

Puerto Rico cannabis industry growth could accelerate under new Governor González, boosting exports, patient access, and regulatory support. read more ​  ​Puerto Rico cannabis industry growth could accelerate under new Governor González, boosting exports, patient access, and regulatory support. read more 

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound. read more ​  ​CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound. read more